Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.48%||166.09||0.7%||$1108.87m|
|MRK||Merck & Co., Inc.||-0.47%||90.59||0.7%||$806.25m|
|LLY||Eli Lilly & Co.||1.90%||313.93||1.1%||$798.53m|
|BMY||Bristol-Myers Squibb Co.||-1.36%||74.54||1.0%||$648.45m|
|SIGA||SIGA Technologies, Inc.||5.66%||26.15||0.0%||$514.56m|
|GBT||Global Blood Therapeutics, Inc.||0.43%||67.04||5.6%||$334.64m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-1.21%||231.01||8.2%||$285.62m|
|HZNP||Horizon Therapeutics Plc||-3.81%||64.90||5.4%||$222.52m|
|KRTX||Karuna Therapeutics, Inc.||-1.34%||273.71||0.0%||$217.12m|
Ironwood Pharmaceuticals, Inc. is a healthcare company, which focuses on the development and commercialization of Gastrointestinal (GI) product opportunities in areas of significant unmet need, leveraging demonstrated expertise and capabilities in GI diseases. Its products include linaclotide, a guanylate cyclase type-C agonists which treats patients irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook Jr., and Gina Bornino Miller on January 5, 1998 and is headquartered in Boston, MA.